Researchers have developed a powerful computational framework that shows how carefully optimized nanotube shapes can amplify ...
DS3610 Enters Clinical Development in Patients with Advanced Solid Tumors as First STING Agonist ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo The first patient has been dosed in a ...
Solid-state battery developer QuantumScape announced it hit another key goal for 2025, beginning shipments of its B1 sample cells featuring separators produced using its proprietary Cobra process. The ...
Anduril and Raytheon have conducted a ground test of an advanced solid rocket motor that could lead to a performance boost for air-to-air weapons. The work involved a static fire test of a rocket ...
WASHINGTON — The Pentagon on Sept. 26 announced three contracts aimed at beefing up U.S. production of solid rocket motors (SRMs), a part of the defense industrial base officials say is vulnerable to ...
Solid Power offers promising solid-state battery tech with potential to help double EV range and cut charging times, addressing key EV adoption barriers. Execution risk is high: scaling manufacturing, ...
Advanced solid-state batteries have long been regarded as the holy grail for electric vehicles and Subaru has joined fellow Japanese brands Toyota and Nissan by working to implement these advanced new ...
Japanese utility firm Kyushu Electric Power has entered a strategic partnership with Taiwan-based ProLogium to jointly develop superfluid inorganic all-solid-state lithium battery 24V modules. Save my ...
We preselected all newsletters you had before unsubscribing.
Physicists recently mapped the hidden shape that underlies the quantum behaviors of a crystal, using a new method that’s expected to become ubiquitous. Famously, at the quantum scale, particles can be ...
Mavrostobart targets CD73 to counteract immune suppression in the tumor microenvironment, maintaining efficacy at high concentrations without the "hook effect." The MORNINGSTAR trial evaluates ...
Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum tolerated dose in up to 50 patients. The FDA granted clearance to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results